|
AP1G1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.105000E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.723500E-03 |
| Normal-vs-Stage2 |
3.316400E-01 |
| Normal-vs-Stage3 |
3.753800E-01 |
| Normal-vs-Stage4 |
5.79669999999366E-05 |
| Stage1-vs-Stage2 |
5.506000E-01 |
| Stage1-vs-Stage3 |
5.209800E-01 |
| Stage1-vs-Stage4 |
3.175800E-02 |
| Stage2-vs-Stage3 |
9.967400E-01 |
| Stage2-vs-Stage4 |
7.544300E-02 |
| Stage3-vs-Stage4 |
5.239600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.015840E-02 |
| Normal-vs-AfricanAmerican |
4.441200E-03 |
| Normal-vs-Asian |
8.920000E-01 |
| Caucasian-vs-AfricanAmerican |
4.360200E-01 |
| Caucasian-vs-Asian |
6.288600E-01 |
| AfricanAmerican-vs-Asian |
5.441800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.102100E-03 |
| Normal-vs-Female |
1.454190E-01 |
| Male-vs-Female |
3.591800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.411300E-04 |
| Normal-vs-Extreme_Weight |
9.50939999999623E-05 |
| Normal-vs-Obese |
1.159640E-01 |
| Normal-vs-Extreme_Obese |
8.229800E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.635400E-01 |
| Normal_Weight-vs-Obese |
8.380400E-02 |
| Normal_Weight-vs-Extreme_Obese |
1.481000E-01 |
| Extreme_Weight-vs-Obese |
6.443700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.249200E-01 |
| Obese-vs-Extreme_Obese |
6.358600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.604300E-02 |
| Normal-vs-Age(41-60Yrs) |
8.533600E-02 |
| Normal-vs-Age(61-80Yrs) |
3.779300E-03 |
| Normal-vs-Age(81-100Yrs) |
2.547900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.472800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.085000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.920000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.299600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.857000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.619400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.684210E-02 |
| Normal-VS-Type2 PRCC |
2.232400E-02 |
| Normal-VS-KIRP CIMP |
1.033870E-02 |
| Normal-VS-Unclassified PRCC |
9.140800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.987600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.844800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.528200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.996600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.470220E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.133200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.735600E-02 |
| Normal-vs-N1 |
7.558400E-02 |
| Normal-vs-N2 |
2.39499999999948E-05 |
| N0-vs-N1 |
8.272800E-01 |
| N0-vs-N2 |
5.9142000000012E-05 |
| N1-vs-N2 |
1.185670E-04 |
|
|
